周三盘中，H&H国际控股（01112）股价大跌6.31%，引起市场关注。截至发稿时，该股报价9.53港元，跌幅收窄至4.51%，成交额1867.73万港元。
这一显著跌幅主要源于公司发布的2024年财务业绩。报告显示，H&H国际控股全年收入约130.52亿元，同比下降6.3%；净亏损5372.1万元，较上年同期由盈转亏。此外，经调整可比纯利约5.41亿元，同比大幅下降30.5%。尽管业绩下滑，公司仍宣布派发末期息0.05港元，加上中期股息0.3港元，全年股息总计0.35港元。
业绩报告中，公司指出高利润营养补充品仍是核心收入增长动力，其中维生素、草本及矿物补充剂以及宠物补充品均实现双位数增长。然而，这一增长被婴幼儿配方奶粉业务的下滑所抵消。公司表示，虽然完成新国标过渡所需时间较预期更长，但其超高端婴幼儿配方奶粉在中国内地市场仍在持续获取市场份额。投资者对公司业绩下滑以及婴幼儿配方奶粉业务面临的挑战表示担忧，这可能是导致股价大跌的主要原因。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.